Natural Killer Cells Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: N592B991743DEN
Market Monitor Global

Abstracts

Cell therapy, a new therapeutic approach that uses a patient’s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body’s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

This report contains market size and forecasts of Natural Killer Cells Therapeutics in Global, including the following market information:

Global Natural Killer Cells Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Natural Killer Cells Therapeutics market was valued at 1442.2 million in 2021 and is projected to reach US$ 2717.8 million by 2028, at a CAGR of 9.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

NK Cell Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Natural Killer Cells Therapeutics include Affimed, Celgene, Fate Therapeutics, Fortress Biotech, Glycostem Therapeutics, Innate Pharma, Nantkwest, Nkarta Therapeutics and NKT Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Natural Killer Cells Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Natural Killer Cells Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Natural Killer Cells Therapeutics Market Segment Percentages, by Type, 2021 (%)

• NK Cell Therapies
• NK Cell Directed Antibodies

Global Natural Killer Cells Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Natural Killer Cells Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Gastrointestinal Diseases
• Immunoproliferative Disorders
• Others

Global Natural Killer Cells Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Natural Killer Cells Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Natural Killer Cells Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Natural Killer Cells Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Affimed
• Celgene
• Fate Therapeutics
• Fortress Biotech
• Glycostem Therapeutics
• Innate Pharma
• Nantkwest
• Nkarta Therapeutics
• NKT Therapeutics
• Ziopharm Oncology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Natural Killer Cells Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Natural Killer Cells Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NATURAL KILLER CELLS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Natural Killer Cells Therapeutics Market Size: 2021 VS 2028
2.2 Global Natural Killer Cells Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Natural Killer Cells Therapeutics Players in Global Market
3.2 Top Global Natural Killer Cells Therapeutics Companies Ranked by Revenue
3.3 Global Natural Killer Cells Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer Cells Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Natural Killer Cells Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer Cells Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Natural Killer Cells Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Natural Killer Cells Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Natural Killer Cells Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 NK Cell Therapies
  4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global Natural Killer Cells Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Natural Killer Cells Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Natural Killer Cells Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Natural Killer Cells Therapeutics Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Gastrointestinal Diseases
  5.1.4 Immunoproliferative Disorders
  5.1.5 Others
5.2 By Application - Global Natural Killer Cells Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Natural Killer Cells Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Natural Killer Cells Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Natural Killer Cells Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Natural Killer Cells Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Natural Killer Cells Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Natural Killer Cells Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Natural Killer Cells Therapeutics Revenue, 2017-2028
  6.3.2 US Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.3.3 Canada Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Natural Killer Cells Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Natural Killer Cells Therapeutics Revenue, 2017-2028
  6.4.2 Germany Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.4.3 France Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.4.5 Italy Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.4.6 Russia Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Natural Killer Cells Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Natural Killer Cells Therapeutics Revenue, 2017-2028
  6.5.2 China Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.5.3 Japan Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.5.6 India Natural Killer Cells Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Natural Killer Cells Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Natural Killer Cells Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.7.3 Israel Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Natural Killer Cells Therapeutics Market Size, 2017-2028
  6.7.5 UAE Natural Killer Cells Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Affimed
  7.1.1 Affimed Corporate Summary
  7.1.2 Affimed Business Overview
  7.1.3 Affimed Natural Killer Cells Therapeutics Major Product Offerings
  7.1.4 Affimed Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Affimed Key News
7.2 Celgene
  7.2.1 Celgene Corporate Summary
  7.2.2 Celgene Business Overview
  7.2.3 Celgene Natural Killer Cells Therapeutics Major Product Offerings
  7.2.4 Celgene Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Celgene Key News
7.3 Fate Therapeutics
  7.3.1 Fate Therapeutics Corporate Summary
  7.3.2 Fate Therapeutics Business Overview
  7.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
  7.3.4 Fate Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Fate Therapeutics Key News
7.4 Fortress Biotech
  7.4.1 Fortress Biotech Corporate Summary
  7.4.2 Fortress Biotech Business Overview
  7.4.3 Fortress Biotech Natural Killer Cells Therapeutics Major Product Offerings
  7.4.4 Fortress Biotech Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Fortress Biotech Key News
7.5 Glycostem Therapeutics
  7.5.1 Glycostem Therapeutics Corporate Summary
  7.5.2 Glycostem Therapeutics Business Overview
  7.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
  7.5.4 Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Glycostem Therapeutics Key News
7.6 Innate Pharma
  7.6.1 Innate Pharma Corporate Summary
  7.6.2 Innate Pharma Business Overview
  7.6.3 Innate Pharma Natural Killer Cells Therapeutics Major Product Offerings
  7.6.4 Innate Pharma Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Innate Pharma Key News
7.7 Nantkwest
  7.7.1 Nantkwest Corporate Summary
  7.7.2 Nantkwest Business Overview
  7.7.3 Nantkwest Natural Killer Cells Therapeutics Major Product Offerings
  7.7.4 Nantkwest Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Nantkwest Key News
7.8 Nkarta Therapeutics
  7.8.1 Nkarta Therapeutics Corporate Summary
  7.8.2 Nkarta Therapeutics Business Overview
  7.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
  7.8.4 Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Nkarta Therapeutics Key News
7.9 NKT Therapeutics
  7.9.1 NKT Therapeutics Corporate Summary
  7.9.2 NKT Therapeutics Business Overview
  7.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
  7.9.4 NKT Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 NKT Therapeutics Key News
7.10 Ziopharm Oncology
  7.10.1 Ziopharm Oncology Corporate Summary
  7.10.2 Ziopharm Oncology Business Overview
  7.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Major Product Offerings
  7.10.4 Ziopharm Oncology Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Ziopharm Oncology Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Natural Killer Cells Therapeutics Market Opportunities & Trends in Global Market
Table 2. Natural Killer Cells Therapeutics Market Drivers in Global Market
Table 3. Natural Killer Cells Therapeutics Market Restraints in Global Market
Table 4. Key Players of Natural Killer Cells Therapeutics in Global Market
Table 5. Top Natural Killer Cells Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Natural Killer Cells Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Natural Killer Cells Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Natural Killer Cells Therapeutics Product Type
Table 9. List of Global Tier 1 Natural Killer Cells Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Natural Killer Cells Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Natural Killer Cells Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Natural Killer Cells Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Affimed Corporate Summary
Table 31. Affimed Natural Killer Cells Therapeutics Product Offerings
Table 32. Affimed Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene Natural Killer Cells Therapeutics Product Offerings
Table 35. Celgene Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Fate Therapeutics Corporate Summary
Table 37. Fate Therapeutics Natural Killer Cells Therapeutics Product Offerings
Table 38. Fate Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Fortress Biotech Corporate Summary
Table 40. Fortress Biotech Natural Killer Cells Therapeutics Product Offerings
Table 41. Fortress Biotech Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Glycostem Therapeutics Corporate Summary
Table 43. Glycostem Therapeutics Natural Killer Cells Therapeutics Product Offerings
Table 44. Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Innate Pharma Corporate Summary
Table 46. Innate Pharma Natural Killer Cells Therapeutics Product Offerings
Table 47. Innate Pharma Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Nantkwest Corporate Summary
Table 49. Nantkwest Natural Killer Cells Therapeutics Product Offerings
Table 50. Nantkwest Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Nkarta Therapeutics Corporate Summary
Table 52. Nkarta Therapeutics Natural Killer Cells Therapeutics Product Offerings
Table 53. Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. NKT Therapeutics Corporate Summary
Table 55. NKT Therapeutics Natural Killer Cells Therapeutics Product Offerings
Table 56. NKT Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Ziopharm Oncology Corporate Summary
Table 58. Ziopharm Oncology Natural Killer Cells Therapeutics Product Offerings
Table 59. Ziopharm Oncology Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Natural Killer Cells Therapeutics Segment by Type in 2021
Figure 2. Natural Killer Cells Therapeutics Segment by Application in 2021
Figure 3. Global Natural Killer Cells Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Natural Killer Cells Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Natural Killer Cells Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2021
Figure 8. By Type - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Affimed Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fate Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Fortress Biotech Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Innate Pharma Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Nantkwest Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. NKT Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Ziopharm Oncology Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)